According to the research report, the global microRNA market size is expected to touch USD 7,757.0million by 2032, from USD 1,252.80 million in 2022, growing with a significant CAGR of 20% from 2023 to 2032.
The microRNA report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global microRNA in conjunction with the geographical landscape of this vertical have also been included in this report.
The report offers intricate dynamics about different aspects of the global microRNA market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global microRNA during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).
Sample Link @ https://www.precedenceresearch.com/sample/3023
This study covers a detailed segmentation of the global microRNA market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global microRNA market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.
Key Players
- Merck KGaA
- QIAGEN
- Thermo Fisher Scientific Inc.
- Synlogic
- GeneCopoeia, Inc
- Horizon Discovery Ltd.
- New England Biolabs
- Quantabio
- NanoString
- BioGenex
- SeqMatic LLC
- Miltenyi Biotec
- Agilent Technologies, Inc
- Promega Corporation
- Abcam plc
- KANEKA CORPORATION
Market Segmentation
By Products
- Instruments
- Consumables
By Services
- Service Type
- Isolation & Purification
- miRNA cDNA Synthesis
- Profiling, Localization, & Quantification
- Functional Analysis
- Real Time PCR
- Microarray
- NGS
- Others
- Specimen
- Whole Blood
- Serum
- Plasma
- FFPE
- Fresh Frozen Tissue
- Others
By Application
- Cancer
- Infectious Diseases
- Immunological Disorder
- Cardiovascular Disease
- Neurological Disease
- Others
By End Use
- Biotechnology & Pharmaceutical Companies
- Academic & Government Research Institutes
- Other end-users
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Research Methodology
The research methodology adopted by analysts for compiling the global microRNA report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global microRNA market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on MicroRNA Market
5.1. COVID-19 Landscape: MicroRNA Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global MicroRNA Market, By Products
8.1. MicroRNA Market Revenue and Volume Forecast, by Products, 2023-2032
8.1.1. Instruments
8.1.1.1. Market Revenue and Volume Forecast (2020-2032)
8.1.2. Consumables
8.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 9. Global MicroRNA Market, By Services
9.1. MicroRNA Market Revenue and Volume Forecast, by Services, 2023-2032
9.1.1. Service Type
9.1.1.1. Market Revenue and Volume Forecast (2020-2032)
9.1.2. Specimen
9.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 10. Global MicroRNA Market, By Application
10.1. MicroRNA Market Revenue and Volume Forecast, by Application, 2023-2032
10.1.1. Cancer
10.1.1.1. Market Revenue and Volume Forecast (2020-2032)
10.1.2. Infectious Diseases
10.1.2.1. Market Revenue and Volume Forecast (2020-2032)
10.1.3. Immunological Disorder
10.1.3.1. Market Revenue and Volume Forecast (2020-2032)
10.1.4. Cardiovascular Disease
10.1.4.1. Market Revenue and Volume Forecast (2020-2032)
10.1.5. Neurological Disease
10.1.5.1. Market Revenue and Volume Forecast (2020-2032)
10.1.6. Others
10.1.6.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 11. Global MicroRNA Market, By End Use
11.1. MicroRNA Market Revenue and Volume Forecast, by End Use, 2023-2032
11.1.1. Biotechnology & Pharmaceutical Companies
11.1.1.1. Market Revenue and Volume Forecast (2020-2032)
11.1.2. Academic & Government Research Institutes
11.1.2.1. Market Revenue and Volume Forecast (2020-2032)
11.1.3. Other end-users
11.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 12. Global MicroRNA Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.1.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.1.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.1.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.1.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.1.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.1.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.1.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.1.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.1.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.2.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.2.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.2.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.2.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.2.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.2.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.2.7.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.2.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.7.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.2.8.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.2.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.2.8.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.3.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.3.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.3.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.3.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.3.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.3.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.3.7.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.3.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.7.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.3.8.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.3.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.3.8.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.4.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.4.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.4.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.4.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.4.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.4.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.4.7.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.4.7.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.7.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.4.8.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.4.8.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.4.8.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.5.5.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.5.5.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.5.5.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Products (2020-2032)
12.5.6.2. Market Revenue and Volume Forecast, by Services (2020-2032)
12.5.6.3. Market Revenue and Volume Forecast, by Application (2020-2032)
12.5.6.4. Market Revenue and Volume Forecast, by End Use (2020-2032)
Chapter 13. Company Profiles
13.1. Merck KGaA
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. QIAGEN
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Thermo Fisher Scientific Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Synlogic
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. GeneCopoeia, Inc
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Horizon Discovery Ltd.
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. New England Biolabs
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Quantabio
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. NanoString
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. BioGenex
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments